We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Hundreds of Medical Practices Are Ineffective or Misguided

By HospiMedica International staff writers
Posted on 26 Jun 2019
Image: Scientists have identified nearly 400 established medical practices that have been found to be ineffective by clinical studies published across three top medical journals (Photo courtesy of Medical Xpress).
Image: Scientists have identified nearly 400 established medical practices that have been found to be ineffective by clinical studies published across three top medical journals (Photo courtesy of Medical Xpress).
A new study identifies almost 400 existing medical reversals, defined as low-value medical practices that are no better than a prior or lesser standard of care.

Researchers at the Oregon Health & Science University (OHSU, Portland, USA), the University of Chicago (IL, USA), and other institutions undertook an analysis of more than 3,000 randomized controlled trials (RCTs) published in three leading medical journals--the Journal of the American Medical Association (JAMA), The Lancet, and the New England Journal of Medicine (NEJM)--to uncover new and improved clinical trials that declare a current medical practice as a medical reversal. Such medical reversals often concern medications, but they can also affect surgical procedures.

The analysis uncovered 396 medical reversals: 154 of them in JAMA, 129 in NEJM, and 113 in The Lancet. Most of the medical reversals occurred in the fields of cardiovascular disease (20%), public health and preventive medicine (12%), and critical care (11%). The most common interventions involved medications (33%), procedures (20%), vitamins and supplements (13%), devices (9%), and system interventions (8%). Most of the reversal studies took place in high-income countries, with only 8% performed in low- or middle-income countries. The study was published on June 11, 2019, in eLife.

“There are a number of lessons that we can take away from our set of results, including the importance of conducting RCTs for both novel and established practices,” said senior author Vinay Prasad, MD, of the OHSU Knight Cancer Institute. “Once an ineffective practice is established, it may be difficult to convince practitioners to abandon its use. By aiming to test novel treatments rigorously before they become widespread, we can reduce the number of reversals in practice and prevent unnecessary harm to patients.”

An example of one such reversal is the use of a thigh-length graduated compression stocking (GSC) to reduce the risk of deep vein thrombosis (DVT) after stroke. GSCs were first used by German physicians in the late 19th century when they noticed that superficial vein thromboses disappeared after the use of compression bandages. But a 2009 study published in The Lancet found that there was no difference in occurrence of symptomatic or asymptomatic DVT between groups, and that more adverse events actually occurring in the GSC group.

Related Links:
Oregon Health & Science University
University of Chicago

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more